![Dr. Yi Lin discusses the future of CART therapy at EHA2024](https://oncodaily.com/pub/uploads/2024/06/GP_KVIaWQAAKm3P-1280x705.jpg)
Photo from Abner Antonio Murray/X
Jun 22, 2024, 12:17
Dr. Yi Lin discusses the future of CART therapy at EHA2024
Abner Antonio Murray, Oncology Fellow at UNC School of Medicine, shared a post on X:
“Exciting insights from EHA2024! Dr. Yi Lin discusses the future of CART therapy, highlighting the feasibility of outpatient treatments in Lymsm! Points:
- Remote patient monitoring enhances safety.
- Outpatient criteria: Decreased tumor bulk, early referral, ECOG PS 0, low inflammatory state, and caregiver compliance.
- Caution with older patients with reduced capacity, cardio/renal/lung complications, CNS involvement, autoimmune/neuro conditions, and inadequate caregiver support.”
Source: Abner Antonio Murray/X
Jul 1, 2024, 03:08